A hyaluronic acid-based niche scaffold with NK92 cell lines and human EGFR (epidermal growth factor receptor)-specific CAR-NK (chimeric antigen-receptor-modified Natural killer) cells were used to prevent relapse and metastases after tumor resection [18]. The gene discussed is EGFR; the disease is neoplasm.